CochLear (OTCMKTS:CHEOY) Upgraded to “Hold” at Zacks Research

CochLear (OTCMKTS:CHEOY – Get Free Report) was upgraded by stock analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a note issued to investors on Monday,Zacks.com reports.

Separately, UBS Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a research note on Thursday, April 23rd. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.

Get CochLear alerts:

View Our Latest Stock Report on CochLear

CochLear Trading Down 1.5%

Shares of OTCMKTS CHEOY opened at $39.12 on Monday. The company has a 50-day simple moving average of $39.27 and a 200-day simple moving average of $64.35. CochLear has a 12 month low of $31.82 and a 12 month high of $105.60.

CochLear Company Profile

(Get Free Report)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

See Also

• Five stocks we like better than CochLear
• Chevron’s Microsoft Deal Turns Natural Gas Into an AI Trade
• Why nVent Could Be a Long-Term AI Infrastructure Winner
• Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
• Apple’s Intel Deal Arrives at the Right Time for Its Stock

Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.